// App-Quantinova.ai

132.0 : Quality of life (QOL) in esophageal cancer patients treated with tri-modality therapy: Is the CROSS protocol better?

Researchers

Presenter

  • Rachel Woo

Principal Investigators

  • Edwin Chan

  • Catherine Vanderwater

  • Charles Cho

  • Jason Wong

  • Wei Xu

  • Qihuang Zhang

  • Geoffrey Liu

  • Beibei Zhang

  • Agnes Cheung

  • Alex Lee

  • Pravin Philip Chacko

  • Ehab Fadhel

  • Zahra Kassam

Medical Centers

  • Department of Radiation Oncology, Stronach Regional Cancer Centre, University of Toronto, Newmarket, ON, Canada

  • Department of Radiation Oncology, Stronach Regional Cancer Centre, University of Toronto, Newmarket, ON, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Department of Medical Physics, Stronach Regional Cancer Centre, Newmarket, ON, Canada

  • Department of Radiation Oncology, Stronach Regional Cancer Centre, University of Toronto, Newmarket, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved